Cisatracurium besilate injection preparation and preparation method thereof

By adjusting the pH value of the injection solution, adding anhydrous glucose and sodium bicarbonate, and using nitrogen protection during the preparation process, the stability of benzylsulfonium atracurum injection was solved, extending the storage time and improving the ingredients stability.

CN119033688AInactive Publication Date: 2024-11-29HANGZHOU HONGYOU PHARM TECH CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411228436.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-03
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing benzenesulfoncis atracurum injection preparations have poor stability under physiological pH and body temperature conditions, and are prone to Hoffmann degradation, resulting in a decrease in titer and a short storage time in a warm environment.

Method used

By adjusting the pH value of the injection solution, adding anhydrous glucose and sodium bicarbonate, and continuously injecting nitrogen during the preparation process to prevent oxidation, controlling the preparation temperature below 20℃, using a 0.22um filter element to filter and fill nitrogen to ensure effectiveness Stability of ingredients.

Benefits of technology

It effectively reduces the occurrence rate of Hoffmann degradation, extends the storage time of benzyl sulfonammonium injection, improves the stability of components during the preparation process, and avoids the oxidative decomposition of active ingredients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005025367780000051
    Figure BDA0005025367780000051
  • Figure BDA0005025367780000061
    Figure BDA0005025367780000061
Patent Text Reader

Abstract

The invention relates to a cisatracurium besilate injection preparation and a preparation method thereof, and relates to the technical field of pharmaceutical preparations. The cisatracurium besilate injection preparation provided by the invention comprises 1 to 3 mg / mL of cisatracurium besilate, 0.125 to 0.5 mg / mL of anhydrous dextrose, 1 to 3 mg / mL of sodium bicarbonate, nitrogen and water for injection, and the pH value of the injection preparation is 5.5 to 6.5. The nitrogen exists in the form of gas and / or dissolved in water. According to the cisatracurium besilate injection preparation provided by the invention, the pH value of the injection preparation is adjusted through matching of the raw materials, so that Hofmann degradation is effectively avoided to a certain extent, and the preservation time of the cisatracurium besilate injection preparation is prolonged.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of pharmaceutical preparations, and in particular to a cisatracurium besylate injection preparation and a preparation method thereof. Background Art

[0002] Cisatracurium besylate is the latest generation of muscle relaxants, widely used in the fields of endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery, etc. This product has the characteristics of metabolism through non-liver and non-renal pathways and cardiovascular protection, which has advantages among similar drugs. Its muscle relaxant effect is 3 times stronger than that of the commonly used clinical atracurium besylate. Cisatracurium besylate is mainly suitable for general anesthesia and can be widely used in endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery and elderly and pediatric patients. Since its first launch in the UK in 1996, this drug has gradually replaced vecuronium bromide and atracurium besylate and has become an indispensable muscle relaxant in clinical practice.

[0003] Although the prior art has disclosed a preparation of cisatracurium besylate injection, there are still problems with the existing preparation of cisatracurium besylate injection and its preparation method. Cisatracurium besylate is a quaternary ammonium salt, which can undergo Hofmann degradation under physiological pH and body temperature conditions. When stored at 5°C, the potency of cisatracurium besylate decreases by 5% per year; when stored at 25°C, its potency decreases by 5% per month; once it is left out of the refrigerator (2-8°C) and placed at 25°C, even if it is put back into the refrigerator, the sample solution must be used up within 21 days. It can be seen that cisatracurium besylate has poor stability in aqueous solution. Summary of the invention

[0004] In order to solve the problem of poor stability of cisatracurium besylate injection preparations in the prior art, the present application provides a cisatracurium besylate injection preparation and a preparation method thereof.

[0005] In a first aspect of the present application, a cisatracurium besylate injection preparation is provided, which adopts the following technical scheme: a cisatracurium besylate injection preparation, comprising 1-3 mg / mL of cisatracurium besylate, 0.125-0.5 mg / mL of anhydrous glucose, 1-3 mg / mL of sodium bicarbonate, nitrogen and water for injection, with a pH of 5.5-6.5; the nitrogen exists in the form of gas and / or dissolved in water.

[0006] The present application uses cisatracurium besylate, anhydrous glucose, sodium bicarbonate and water for injection as raw materials to prepare a cisatracurium besylate injection preparation, which can slightly adjust the pH of the injection preparation and reduce the occurrence rate of Hofmann degradation to a certain extent. At the same time, nitrogen can ensure that the injection has good antioxidant properties and prevent the active ingredients in the injection from being oxidized and decomposed.

[0007] Optionally, the cisatracurium besylate injection preparation includes 2 mg / mL of cisatracurium besylate, 0.25 mg / mL of anhydrous glucose, 2 mg / mL of sodium bicarbonate, nitrogen and water for injection, with a pH of 5.5-6.5; the nitrogen exists in the form of gas and / or dissolved in water.

[0008] The present application can further ensure that the prepared injection has good stability by further optimizing the components of each raw material.

[0009] A method for preparing a cisatracurium besylate injection preparation comprises the following steps: Step 1: Weigh 70-90% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving the prescribed amount of cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, quantifying them with water for injection; nitrogen is introduced into the solution throughout this step; Step 3: The solution obtained after mixing in step 2 is filtered through a sterilizing grade filter element and then potted. During the potting process, nitrogen is filled for protection to control the residual oxygen content of the headspace gas to a standard of ≤2.0%.

[0010] The preparation method of the cisatracurium besylate injection preparation in the present application specifies that step 2 of introducing nitrogen into the solution throughout the entire process can ensure that the active ingredient of cisatracurium besylate will not be oxidized and decomposed during the preparation process.

[0011] Optionally, the entire process from step 1 to step 3 is carried out at an ambient temperature below 20°C.

[0012] By adopting the above technical solution, the present application can avoid the degradation of cisatracurium besylate due to excessively high temperature during the preparation process.

[0013] Optionally, in step 2, the dissolving method is stirring dissolving.

[0014] The present application can ensure that the active ingredients in the prepared cisatracurium besylate injection are evenly mixed by limiting the dissolution method.

[0015] Optionally, in step three, nitrogen filling is performed before and after potting.

[0016] The present application can avoid the influence of oxygen on cisatracurium besylate by limiting the oxygenation before and after the filling. Optionally, in step three, the sterilization grade filter element is a 0.22um filter element.

[0017] The present application can effectively remove impurities and microorganisms in the solution by limiting the pore size of the sterilization-grade filter element.

[0018] Optionally, in step 1, the temperature of the water for injection is ≤20°C.

[0019] The present application can further avoid the degradation of cisatracurium besylate due to excessively high temperature by limiting the temperature of the water for injection.

[0020] In summary, the present application includes at least one of the following beneficial technical effects: 1. The cisatracurium besylate injection preparation provided in the present application adjusts the pH of the injection preparation by combining raw materials to effectively avoid the occurrence of Hofmann degradation to a certain extent, thereby extending the shelf life of the cisatracurium besylate injection preparation.

[0021] 2. The preparation method of cisatracurium besylate injection provided in the present application maintains the introduction of nitrogen during the preparation process, and at the same time limits the entire preparation process to be carried out at an ambient temperature below 20°C, thereby effectively avoiding the degradation of the active ingredient in cisatracurium besylate injection during the preparation process. DETAILED DESCRIPTION

[0022] The present application is further described in detail below with reference to the embodiments.

[0023] Example 1 Cisatracurium besylate injection preparation, composed of the following components: Cisatracurium besylate 1mg, anhydrous glucose 0.125mg, sodium bicarbonate 1mg, water for injection and nitrogen; A method for preparing cisatracurium besylate injection comprises the following steps: Step 1: Weigh 70% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, quantitatively adding the remaining water for injection; nitrogen is introduced into the solution throughout this step; Step 3: Filter the solution obtained after mixing in step 2 through a 0.22um filter element and then seal it. During the sealing process, nitrogen is filled for protection to control the residual oxygen content of the headspace gas to ≤2.0%; The whole process from step 1 to step 3 is carried out at an ambient temperature below 20°C.

[0024] Example 2 Cisatracurium besylate injection preparation, composed of the following components: Cisatracurium besylate 3mg, anhydrous glucose 0.5mg, sodium bicarbonate 3mg, water for injection and nitrogen; A method for preparing cisatracurium besylate injection comprises the following steps: Step 1: Weigh 70% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, quantitatively adding the remaining water for injection; nitrogen is introduced into the solution throughout this step; Step 3: Filter the solution obtained after mixing in step 2 through a 0.22um filter element and then seal it. During the sealing process, nitrogen is filled for protection to control the residual oxygen content of the headspace gas to ≤2.0%; The whole process from step 1 to step 3 is carried out at an ambient temperature below 20°C.

[0025] Example 3 Cisatracurium besylate injection preparation, composed of the following components: Cisatracurium besylate 2mg, anhydrous glucose 0.25mg, sodium bicarbonate 2mg, water for injection and nitrogen; A method for preparing cisatracurium besylate injection comprises the following steps: Step 1: Weigh 70% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, quantitatively adding the remaining water for injection; nitrogen is introduced into the solution throughout this step; Step 3: Filter the solution obtained after mixing in step 2 through a 0.22um filter element and then seal it. During the sealing process, nitrogen is filled for protection to control the residual oxygen content of the headspace gas to ≤2.0%; The whole process from step 1 to step 3 is carried out at an ambient temperature below 20°C.

[0026] Example 4 Cisatracurium besylate injection preparation, composed of the following components: Cisatracurium besylate 1mg, anhydrous glucose 0.25mg, sodium bicarbonate 2mg, water for injection and nitrogen; A method for preparing cisatracurium besylate injection comprises the following steps: Step 1: Weigh 70% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, quantitatively adding the remaining water for injection; nitrogen is introduced into the solution throughout this step; Step 3: Filter the solution obtained after mixing in step 2 through a 0.22um filter element and then seal it. During the sealing process, nitrogen is filled for protection to control the residual oxygen content of the headspace gas to ≤2.0%; The whole process from step 1 to step 3 is carried out at an ambient temperature below 20°C.

[0027] Example 5 Cisatracurium besylate injection preparation, composed of the following components: Cisatracurium besylate 3mg, anhydrous glucose 0.25mg, sodium bicarbonate 3mg, water for injection and nitrogen; A method for preparing cisatracurium besylate injection comprises the following steps: Step 1: Weigh 70% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, quantitatively adding the remaining water for injection; nitrogen is introduced into the solution throughout this step; Step 3: Filter the solution obtained after mixing in step 2 through a 0.22um filter element and then seal it. During the sealing process, nitrogen is filled for protection to control the residual oxygen content of the headspace gas to ≤2.0%; The whole process from step 1 to step 3 is carried out at an ambient temperature below 20°C.

[0028] Comparative Example 1 Cisatracurium besylate injection preparation, composed of the following components: Cisatracurium besylate 1 mg, anhydrous glucose 0.25 mg, water for injection and nitrogen; A method for preparing cisatracurium besylate injection comprises the following steps: Step 1: Weigh 70% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, quantitatively adding the remaining water for injection; nitrogen is introduced into the solution throughout this step; Step 3: Filter the solution obtained after mixing in step 2 through a 0.22um filter element and then seal it. During the sealing process, nitrogen is filled for protection to control the residual oxygen content of the headspace gas to ≤2.0%; The whole process from step 1 to step 3 is carried out at an ambient temperature below 20°C.

[0029] Comparative Example 2 Cisatracurium besylate injection preparation, composed of the following components: Cisatracurium besylate 1mg, anhydrous glucose 0.125mg, sodium bicarbonate 1mg, water for injection and nitrogen; A method for preparing cisatracurium besylate injection comprises the following steps: Step 1: Weigh 70% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, quantitatively adding the remaining water for injection; nitrogen is introduced into the solution throughout this step; Step 3: Filter the solution obtained after mixing in step 2 through a 0.22um filter element and then seal it. During the sealing process, nitrogen is filled for protection to control the residual oxygen content of the headspace gas to ≤2.0%; The whole process from step 1 to step 3 is carried out at an ambient temperature below 35°C.

[0030] Comparative Example 3 Cisatracurium besylate injection preparation, composed of the following components: Cisatracurium besylate 1mg, anhydrous glucose 0.125mg, sodium bicarbonate 1mg and water for injection; A method for preparing cisatracurium besylate injection comprises the following steps: Step 1: Weigh 70% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, using the remaining water for injection for quantitative determination; Step 3: Filter the solution obtained after mixing in step 2 through a 0.22um filter element and then seal, and control the residual oxygen content of the headspace gas to ≤2.0%; The whole process from step 1 to step 3 is carried out at an ambient temperature below 20°C.

[0031] The cisatracurium besylate injection preparations in the above Examples 1-5 and Comparative Examples 1-3 and commercially available cisatracurium besylate injection samples were subjected to long-term stability tests. The samples were placed under long-term conditions (2°C-8°C) for 6 months, and samples were taken at 0, 3, and 6 months, respectively. The appearance, cisatracurium besylate content (content), and total impurity content (total impurities) were compared, and the results are shown in the table below.

[0032] Table 1 Stability test results Combining Examples 1-5, Comparative Examples 1-3 and Table 1, it can be seen that the content of cisatracurium besylate in each sample decreased slightly under the condition of 6 months, and the total impurity content increased to a certain extent, among which the content and related substance levels of Examples 1-5 were better than those of the commercially available cisatracurium besylate injection samples. And combining Example 1 and Comparative Examples 1-3, it can be seen that sodium bicarbonate, nitrogen conditions and low temperature treatment conditions can directly affect the stability of the prepared cisatracurium besylate injection preparation.

[0033] The above are all preferred embodiments of the present application, and the protection scope of the present application is not limited thereto. Therefore, any equivalent changes made according to the structure, shape, and principle of the present application should be included in the protection scope of the present application.

Claims

1. A cisatracurium besylate injection preparation, characterized in that: The invention comprises 1-3 mg / mL of cisatracurium besylate, 0.125-0.5 mg / mL of anhydrous glucose, 1-3 mg / mL of sodium bicarbonate, nitrogen and water for injection, and the pH value is 5.5-6.5; the nitrogen exists in the form of gas and / or dissolved in water.

2. The cisatracurium besylate injection preparation according to claim 1, characterized in that: The invention comprises 2 mg / mL of cisatracurium besylate, 0.25 mg / mL of anhydrous glucose, 2 mg / mL of sodium bicarbonate, nitrogen and water for injection, and the pH value is 5.5-6.5; the nitrogen exists in the form of gas and / or dissolved in water.

3. The method for preparing the cisatracurium besylate injection preparation according to claim 1 or 2, characterized in that: The following steps are involved: Step 1: Weigh 70-90% of the water for injection used, and continuously introduce nitrogen into the weighed water for injection; Step 2: dissolving the prescribed amount of cisatracurium besylate, anhydrous glucose and sodium bicarbonate in the water for injection weighed in step 1, and after the added substances are completely dissolved, quantifying them with water for injection; nitrogen is introduced into the solution throughout this step; Step 3: The solution obtained after mixing in step 2 is filtered through a sterilizing grade filter and then sealed. During the sealing process, nitrogen is filled for protection to control the residual oxygen content in the headspace to a standard of ≤2.0%.

4. The method for preparing cisatracurium besylate injection according to claim 3, characterized in that: The whole process from step 1 to step 3 is carried out at an ambient temperature below 20°C.

5. The method for preparing cisatracurium besylate injection according to claim 3, characterized in that: In step 2, the dissolving method is stirring dissolving.

6. The method for preparing cisatracurium besylate injection according to claim 3, characterized in that: In step three, nitrogen filling is performed before and after potting.

7. The method for preparing cisatracurium besylate injection according to claim 3, characterized in that: In step three, the sterilization grade filter element is a 0.22um filter element.

8. A method according to claim 3, characterized in that: In step 1, the temperature of the water for injection is ≤20°C.

Citation Information

Patent Citations

  • Cisatracurium besylate composition for injection

    CN107638391A

  • Cisatracurium besilate injection preparation and preparation method thereof

    CN114306230A

  • Preparation method of preservative-free cisatracurium besilate injection

    CN115245485A

  • Methods for improving relaxation of striated myocytes

    WO2023280988A1